BeStock  

Ironwood Pharmaceuticals IRWD

US equityMarket cap rank #3604Drug Manufacturers - Specialty & Generic
$3.75 +$0.12 (+3.31%)
Pre-market · Oct 8, 9:00 am ET · After hours $3.54 -5.59%
Open$3.58
Prev close$3.63
Day range$3.54 – $3.87
Volume2.05M
Market cap$619.65M
P/E (TTM)4.7
Dividend yield–

IRWD Stock News

Headlines matching Ironwood Pharmaceuticals or the IRWD ticker, most recent first.

  • Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy RatingMarket news · 16 Jul 2026 · Direct mention
  • Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $5Market news · 6 May 2026 · Direct mention
  • Analysts' Top Healthcare Picks: Ironwood Pharma (IRWD), Sionna Therapeutics, Inc. (SION)TipRanks · 14 May 2026 · Direct mention
  • OneMedNet Collaborates With Inka Health To Provide Access To U.S. Real‐World Oncology Data Via IRWD Platform Powered By Palantir FoundryBenzinga · 1 Apr 2026 · Direct mention
  • Ironwood Pharmaceuticals(IRWD.US) Director Sells US$20.53 Million in Common StockMarket news · 18 Mar 2026 · Direct mention
  • Citizens JMP Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 26 Feb 2026 · Direct mention
  • Citizens JMP Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Announces Target Price $8 PositiveMarket news · 5 Jan 2026 · Direct mention
  • Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Raises Target Price to $5 PositiveMarket news · 5 Jan 2026 · Direct mention
  • Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Raises Target Price to $5.7 PositiveMarket news · 5 Jan 2026 · Direct mention
  • Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1Market news · 1 May 2025 · Direct mention
  • Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1.1 NegativeMarket news · 29 Apr 2025 · Direct mention
  • Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating PositiveMarket news · 26 Apr 2025 · Direct mention
  • Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1 NegativeMarket news · 17 Apr 2025 · Direct mention
  • Leerink Partners Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1Market news · 16 Apr 2025 · Direct mention
  • Jefferies Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $0.7 NegativeMarket news · 16 Apr 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on IRWD.

Leave a comment

Scroll to Top